YV

Yamanouchi Venture Capital

North America, California, United States, Palo Alto

Description

Yamanouchi Venture Capital is a venture capital.

Investor Profile

Yamanouchi Venture Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C rounds (top funding stages).
  • Majority of deals are located in Switzerland, United States.
  • Strong thematic focus on Health Care, Biotechnology, Food and Beverage.

Stage Focus

  • Series A (75%)
  • Series C (25%)

Country Focus

  • Switzerland (75%)
  • United States (25%)

Industry Focus

  • Health Care
  • Biotechnology
  • Food And Beverage
  • Wellness
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yamanouchi Venture Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
NB
North America, Maryland, United States, Gaithersburg
Co-Investments: 1
Boston Millennia Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
JAFCO Asia
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Co-Investments: 3
CMEA Ventures
North America, California, United States, San Francisco
Co-Investments: 1
AV
Asia, Andhra Pradesh, India, Hyderabad
Co-Investments: 2
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 1

What are some of recent deals done by Yamanouchi Venture Capital?

Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series ADec 1, 2006
Amount Raised: $10,300,000
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series AMar 21, 2005
Amount Raised: $2,635,081
Predix Pharmaceuticals

Boston, Massachusetts, United States

Predix is a drug discovery and development company

Health CareMedicalPharmaceutical
Series CJan 27, 2005
Amount Raised: $43,000,000
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series AAug 16, 2004
Amount Raised: $14,813,553

Find More Investors Like Yamanouchi Venture Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Yamanouchi Venture Capital | Pipeseed